Literature DB >> 8019139

Three-dimensional structure of echistatin and dynamics of the active site.

Y Chen1, A K Suri, D Kominos, G Sanyal, A M Naylor, S M Pitzenberger, V M Garsky, R M Levy, J Baum.   

Abstract

The snake venom protein echistatin contains the cell recognition sequence Arg-Gly-Asp and is a potent inhibitor of platelet aggregation. The three-dimensional structure of echistatin and the dynamics of the active RGD site are presented. A set of structures was determined using the Distance Geometry method and subsequently refined by Molecular Dynamics and energy minimization. Disulfide pairings are suggested, based on violations of experimental constraints. The structures satisfy 230 interresidue distance constraints, derived from nuclear Overhauser effect measurements, five hydrogen-bonding constraints, and 21 torsional constraints from vicinal spin-spin coupling constants. The segment from Gly5 to Cys20 and from Asp30 to Asn42 has a well-defined conformation and the Arg-Gly-Asp sequence, which adopts a turn-like structure, is located at the apex of a nine-residue loop connecting the two strands of a distorted beta-sheet. The mobility of the Arg-Gly-Asp site has been quantitatively characterized by 15N relaxation measurements. The overall correlation time of echistatin was determined from fluorescence measurements, and was used in a model-free analysis to determine internal motional parameters. The active site has order parameters of 0.3-0.5, i.e., among the smallest values ever observed at the active site of a protein. Correlation of the flexible region of the protein as characterized by relaxation experiments and the NMR solution structures was made by calculating generalized order parameters from the ensemble of three-dimensional structures. The motion of the RGD site detected experimentally is more extensive than a simple RGD loop 'wagging' motional model, suggested by an examination of superposed solution structures.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8019139     DOI: 10.1007/bf00179342

Source DB:  PubMed          Journal:  J Biomol NMR        ISSN: 0925-2738            Impact factor:   2.835


  60 in total

1.  Analysis of the backbone dynamics of the ribonuclease H domain of the human immunodeficiency virus reverse transcriptase using 15N relaxation measurements.

Authors:  R Powers; G M Clore; S J Stahl; P T Wingfield; A Gronenborn
Journal:  Biochemistry       Date:  1992-09-29       Impact factor: 3.162

2.  Loop mobility in a four-helix-bundle protein: 15N NMR relaxation measurements on human interleukin-4.

Authors:  C Redfield; J Boyd; L J Smith; R A Smith; C M Dobson
Journal:  Biochemistry       Date:  1992-11-03       Impact factor: 3.162

Review 3.  VLA proteins in the integrin family: structures, functions, and their role on leukocytes.

Authors:  M E Hemler
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

Review 4.  Integrins: a family of cell surface receptors.

Authors:  R O Hynes
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

5.  Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors.

Authors:  R Pytela; M D Pierschbacher; M H Ginsberg; E F Plow; E Ruoslahti
Journal:  Science       Date:  1986-03-28       Impact factor: 47.728

6.  A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules.

Authors:  A Kumar; R R Ernst; K Wüthrich
Journal:  Biochem Biophys Res Commun       Date:  1980-07-16       Impact factor: 3.575

7.  Chemical synthesis of echistatin, a potent inhibitor of platelet aggregation from Echis carinatus: synthesis and biological activity of selected analogs.

Authors:  V M Garsky; P K Lumma; R M Freidinger; S M Pitzenberger; W C Randall; D F Veber; R J Gould; P A Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

8.  The secondary structure of echistatin from 1H-NMR, circular-dichroism and Raman spectroscopy.

Authors:  V Saudek; R A Atkinson; P Lepage; J T Pelton
Journal:  Eur J Biochem       Date:  1991-12-05

9.  1H NMR studies of echistatin in solution. Sequential resonance assignments and secondary structure.

Authors:  C Dalvit; H Widmer; G Bovermann; R Breckenridge; R Metternich
Journal:  Eur J Biochem       Date:  1991-12-05

10.  Backbone dynamics of the Bacillus subtilis glucose permease IIA domain determined from 15N NMR relaxation measurements.

Authors:  M J Stone; W J Fairbrother; A G Palmer; J Reizer; M H Saier; P E Wright
Journal:  Biochemistry       Date:  1992-05-12       Impact factor: 3.162

View more
  5 in total

1.  Dynamics and functional differences between dendroaspin and rhodostomin: insights into protein scaffolds in integrin recognition.

Authors:  Chun-Ho Cheng; Yi-Chun Chen; Jia-Hau Shiu; Yao-Tsung Chang; Yung-Sheng Chang; Chun-Hau Huang; Chiu-Yueh Chen; Woei-Jer Chuang
Journal:  Protein Sci       Date:  2012-11-06       Impact factor: 6.725

2.  Internal mobility of cyclic RGD hexapeptides studied by 13C NMR relaxation and the model-free approach.

Authors:  J Briand; K D Kopple
Journal:  J Biomol NMR       Date:  1995-12       Impact factor: 2.835

3.  Conformation and concerted dynamics of the integrin-binding site and the C-terminal region of echistatin revealed by homonuclear NMR.

Authors:  Daniel Monleón; Vicent Esteve; Helena Kovacs; Juan J Calvete; Bernardo Celda
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

4.  The role of beta 1 integrins in adhesion of two breast carcinoma cell lines to a model endothelium.

Authors:  R D Bliss; J A Kirby; D A Browell; T W Lennard
Journal:  Clin Exp Metastasis       Date:  1995-05       Impact factor: 5.150

5.  Effect of P to A mutation of the N-terminal residue adjacent to the Rgd motif on rhodostomin: importance of dynamics in integrin recognition.

Authors:  Jia-Hau Shiu; Chiu-Yueh Chen; Yi-Chun Chen; Yao-Tsung Chang; Yung-Sheng Chang; Chun-Hao Huang; Woei-Jer Chuang
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.